Cargando…
Alopecia areata after COVID-19 vaccination
The coronavirus disease 2019 (COVID-19) vaccines are authorized for use in numerous countries worldwide. Several cutaneous findings are reported after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination. Here, we report the case of a patient with a rapid onset of alopecia areata...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844677/ https://www.ncbi.nlm.nih.gov/pubmed/35223675 http://dx.doi.org/10.7774/cevr.2022.11.1.129 |
_version_ | 1784651524030332928 |
---|---|
author | Gallo, Giuseppe Mastorino, Luca Tonella, Luca Ribero, Simone Quaglino, Pietro |
author_facet | Gallo, Giuseppe Mastorino, Luca Tonella, Luca Ribero, Simone Quaglino, Pietro |
author_sort | Gallo, Giuseppe |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) vaccines are authorized for use in numerous countries worldwide. Several cutaneous findings are reported after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination. Here, we report the case of a patient with a rapid onset of alopecia areata immediately after receiving the second dose of the COVID-19 vaccine. Alopecia areata is a common autoimmune disease leading to non-scarring hair loss. Among the many cutaneous adverse effects reported after the anti-SARS-COV2 vaccination, no episodes of alopecia areata have been described to date. In this paper, we report the first case of alopecia areata after COVID-19 vaccination described in the literature with a revision of cases of alopecia areata reported after other types of vaccination. Although the significance of these skin reactions is not yet known, further studies will certainly clarify whether the development of alopecia areata or other forms of immune-mediated reactions could represent a positive prognostic factor regarding immune protection from SARS-CoV-2. |
format | Online Article Text |
id | pubmed-8844677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Vaccine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-88446772022-02-24 Alopecia areata after COVID-19 vaccination Gallo, Giuseppe Mastorino, Luca Tonella, Luca Ribero, Simone Quaglino, Pietro Clin Exp Vaccine Res Covid-19 Special The coronavirus disease 2019 (COVID-19) vaccines are authorized for use in numerous countries worldwide. Several cutaneous findings are reported after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination. Here, we report the case of a patient with a rapid onset of alopecia areata immediately after receiving the second dose of the COVID-19 vaccine. Alopecia areata is a common autoimmune disease leading to non-scarring hair loss. Among the many cutaneous adverse effects reported after the anti-SARS-COV2 vaccination, no episodes of alopecia areata have been described to date. In this paper, we report the first case of alopecia areata after COVID-19 vaccination described in the literature with a revision of cases of alopecia areata reported after other types of vaccination. Although the significance of these skin reactions is not yet known, further studies will certainly clarify whether the development of alopecia areata or other forms of immune-mediated reactions could represent a positive prognostic factor regarding immune protection from SARS-CoV-2. The Korean Vaccine Society 2022-01 2022-01-31 /pmc/articles/PMC8844677/ /pubmed/35223675 http://dx.doi.org/10.7774/cevr.2022.11.1.129 Text en © Korean Vaccine Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Covid-19 Special Gallo, Giuseppe Mastorino, Luca Tonella, Luca Ribero, Simone Quaglino, Pietro Alopecia areata after COVID-19 vaccination |
title | Alopecia areata after COVID-19 vaccination |
title_full | Alopecia areata after COVID-19 vaccination |
title_fullStr | Alopecia areata after COVID-19 vaccination |
title_full_unstemmed | Alopecia areata after COVID-19 vaccination |
title_short | Alopecia areata after COVID-19 vaccination |
title_sort | alopecia areata after covid-19 vaccination |
topic | Covid-19 Special |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844677/ https://www.ncbi.nlm.nih.gov/pubmed/35223675 http://dx.doi.org/10.7774/cevr.2022.11.1.129 |
work_keys_str_mv | AT gallogiuseppe alopeciaareataaftercovid19vaccination AT mastorinoluca alopeciaareataaftercovid19vaccination AT tonellaluca alopeciaareataaftercovid19vaccination AT riberosimone alopeciaareataaftercovid19vaccination AT quaglinopietro alopeciaareataaftercovid19vaccination |